General information

MRSA: What you should know
MRSA Consumer Fact Sheet
Fighting Superbugs- Congressional Quarterly Report: topical overview of antibiotic resistance
Q&A's
: questions about antibiotics & resistance

Handwashing: why it's so important
Table of common antibiotics
Antibacterial Soaps and Cleaners: reason for concern?
Español: Antibiotic Use
Donate to APUA
Tufts Health Care Institute and APUA partnership on education -- fact sheets for consumer and providers (March 2003)

Educational materials...list
Book: The Antibiotic Paradox
Newsletter with Ask the Expert columns
Pamphlet for patients
Factsheets: read about antibiotic resistance

References
Publications: books, journal articles, references
Scientific American
article on ABR
FDA Consumer reports that antibiotic resistance is becoming a public-health nightmare:

Website links...list

Print this Page

Email this Page


What is antibiotic resistance & why is it a problem?

Since the 1940s, antibiotics have been the cornerstone of infectious disease therapy. Their remarkable healing power invites widespread and often inappropriate use, which leads to antibiotic resistance among bacteria and consequent treatment complications.
     Antibiotics are prescribed for infections caused by bacteria. Antibiotics should not be used for infections caused by viruses such as the common cold and flu …

… how & when to take antibiotics
… resistance to multiple drugs
… factors that contribute to antibiotic resistance
… Penicillin, the first miracle drug

Don't leave here without this advice...

Here are some actions you can take to limit the development of antibiotic resistance--

  • Do not demand antibiotics from your physician.When given antibiotics, take them exactly as prescribed and complete the full course of treatment; do not hoard pills for later use or share leftover antibiotics.Wash your hands properly to reduce the chance of getting sick and spreading infection.Wash fruits and vegetables thoroughly; avoid raw eggs and undercooked meat, especially in ground form. (The majority of food items which cause diseases are raw or undercooked foods of animal origin such as meat, milk, eggs, cheese, fish or shellfish.)
  • When protecting a sick person whose defenses are weakened, soaps and other products with antibacterial chemicals are helpful, but should be used according to established procedures and guidelines.
  • Read more: Unecessary Deaths: The Human and Financial Costs of Hospital Infections by the Committee to Reduce Infection Deaths (RID)

Multiple-drug resistance
Sometimes bacteria find a way to fight the antibiotic you are taking and your infection won't go away. When antibiotic resistance develops, your doctor must prescribe a different antibiotic in order to fight the infection.
Multiple-drug resistance occurs when bacteria are resistant to more than one antibiotic. This is generally the rule rather than the exception among resistant bacteria. This situation has largely occurred through the sequential use of multiple different antibiotics. The first antibiotic began by selecting a single resistance gene. Eventually, however, bacteria resistant to the first antibiotic picked up resistance to others as they were introduced into the environment. It's like a snowball rolling downhill, becoming bigger and stronger and not losing what it had acquired before.

Factors that contribute to antibiotic resistance
  • misuse and overuse of antibiotics in humans, animals and agriculture
  • demand for antibiotics when antibiotics are not appropriate
  • failure to finish an antibiotic prescription
  • availability of antibiotics without a prescription in some countries
Penicillin: the First Miracle Drug
Alexander Fleming, a Scottish scientist, is credited with discovering the first antibiotic, penicillin. In 1928, he noticed that bacteria could not survive on a plate that contained a mold commonly found on bread. He went on to show that the effect was due to a diffusible substance made by the mold. However, penicillin was not available to the general public until the early 1940s when scientists learned how to produce and purify large amounts of penicillin.

In fact, technically speaking, Fleming may have rediscovered a substance that had been found before. In 1896, the French medical student Ernest Duchesne showed antibiotic properties of the mold Penicillium, but did not report a connection between the fungus and a substance that had antibacterial properties. Penicillium was unknown to the scientific community until Fleming discovered the phenomenon and the substance, and named it penicillin.

In 1895, there was a report by an Italian researcher, Vincenzo Tiberio, describing a natural substance from molds which had antibacterial properties resembling penicillin. Yet another report describes a professor at John Hopkins University in Baltimore who showed his students an agar plate with a mold which inhibited bacterial growth. (Levy, S.B. The Antibiotic Paradox. How Misuse of Antibiotics Destroys Their Curative Powers. Perseus Books, 2002). So perhaps others had seen and described the phenomenon, but Fleming was the first to bring such a substance to wide scientific attention.

Patient Behaviors and Beliefs Regarding Antibiotic Use: Implications for Clinical Practice - Poster 1

Patient Behaviors and Beliefs Regarding Antibiotic Use: Implications for Clinical Practice - Poster 2

Alliance for the Prudent Use of Antibiotics (APUA) Consumer Fact Sheet on Free or Discounted Antibiotic Promotions

APUA MRSA Survey Results

MRSA Consumer Fact Sheet

A Report of the Facts about Antibiotics in Animals and the Impact on Resistance (FAAIR) Project

FULL REPORT- The Need to Improve Antimicrobial Use in Agriculture Ecological and Human Health Consequences
http://www.journals.uchicago.edu/toc/cid/34/s3
EXECUTIVE SUMMARY- Global Antimicrobial Resistance Alerts and Implications
http://www.journals.uchicago.edu/doi/pdf/10.1086/430780
INTRODUCTION
http://www.journals.uchicago.edu/doi/pdf/10.1086/432443
EXECUTIVE SUMMARY- Select Findings, Conclusions, and Policy Recommendations
http://www.journals.uchicago.edu/doi/pdf/10.1086/430781

APUA's letter to the United States Department of Health & Human Services regarding the opposition to the EPA's recent decision to approve the use of gentamicin, a critically important medicine for humans, for spray treatment for the plant disease of fireblight in apples.

Matheson- Ferguson Bill Aims to Curb Drug-Resistant Super Bugs: October 19, 2007

Bad Bugs, Few Drugs, Infectious Diseases Society of America, July 2004.

Dr. Phil on MRSA

WHO Global Strategy     September, 2001
To combat the growing threat of antimicrobial resistance, the World Health Organization (WHO) released its first Global Strategy for Containment of Antimicrobial Resistance. APUA developed one of the technical documents supporting the WHO Global Strategy, Antibiotic resistance: synthesis of recommendations by expert policy groups.

US Interagency Action Plan Jan. 18, 2001 APUA's comments on the draft Action Plan

ICAAC Symposium: Global Resistance Day Sept. 2000 "Global Resistance Day: Unprecedented and Promising", by Robert A. Weinstein, MD.

Drug Resistance Threatens to Reverse Medical Progress- WHO Report read more

Laboratory Capacity to Detect Antimicrobial Resistance news article

World Health Organization. "Strengthening Global Preparedness for Defense against Infectious Disease Threats." Statement to the United States Senate Committee on Foreign Relations Hearing on The Threat of Bioterrorism and the Spread of Infectious Diseases. 5 September 2001. http://www.who.int/emc/pdfs/Senate_hearing.pdf(24 November 2002) http://www.espionageinfo.com/Gu-In/Infectious-Disease-Threats-to-Security.html

The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. [Clin Infect Dis. 2008 Jan 15;46(2):155-64]

Societal costs versus savings from wild-card patent extension legislation to spur critically needed antibiotic development Spellberg B et al. 2007 Jun;35(3):167-74 http://www.springerlink.com/content/6134445712341065/fulltext.pdf

Antibiotic Resistance: Federal Agencies Need to Better Focus Efforts to Address Risk to Humans From Antibiotic Use in Animals, Government Accountability Office, April 2004. Congress' nonpartisan auditing office finds federal agencies aren't doing enough to pin down the precise health risks posed by antibiotic use on farms.

Impacts of Antibiotic-Resistant Bacteria, Office of Technology Assessment, www.theblackvault.com/documents/ota/Ota_1/DATA/1995/9503.PDF September 1995. A nonpartisan federal agency reports on the history of antibiotic resistance and discusses federal policy options to combat it.

Kaufman, Marc, "Bayer Seeks Reprieve for Animal Antibiotic," The Washington Post, Sept. 2, 2005, p. A4. Bayer Corp. has asked the FDA to allow it to keep selling Baytril, its controversial animal antibiotic, while it fights the ban in federal court.

"Government Alleges Iowa Dairy Sold Cows with Antibiotics In Meat," The Associated Press, Aug. 10, 2007. The federal government has filed a complaint alleging that an Iowa dairy has violated FDA guidelines by selling culled cows with more than the allowable amount of antibiotics in their systems.

Graham, Judith, " 'Super Bug' Bill Targets Hospitals," Chicago Tribune, April 30, 2007, p. A1. Illinois may become the first state to require hospitals to implement programs that combat the drug-resistant bacterium MRSA (methicillin-resistant staphylococcus aureus)

The 2001 Federal Interagency Action Plan to Combat Antimicrobial Resistance," Union of Concerned Scientists www.ucsusa.org

Performance Measures May Lead to Overuse of Antibiotics July 10, 2006

"4/29/08: APUA issues a Press Release responding to the Pew Commission on Industrial Farm Animal Production (PCIFAP)'s report and commending legislative leadership in containing antibiotic resistance". Read APUA's Press Release 4/29/08.

APUA submits a written testimony for the FDA hearing on antimicrobial resistance 4/28/2008 [Docket No. FDA-2008-N-0225]". Read APUA's testimony.

 

ALLIANCE FOR THE PRUDENT USE OF ANTIBIOTICS © 1999

| Home | About APUA | Int'l Chapters | Contact Us | Search | Site Map |
|
Consumer Information | Practitioner Information | Research & Surveillance | News |